(Source: Dual Therapeutic Benefits of Glycemic Control and Weight Management In contrast to many conventional therapies, GLP-1 analogues decrease appetite and encourage weight loss in addition to controlling blood sugar levels
Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County
Key CA requirements: Important change: As of January 2026, Californias Medi-Cal will no longer cover GLP-1 medications for weight loss theyre reclassifying them as non-covered (www.cmadocs.org)
FDA-approved medications for Cushing's syndrome include osilodrostat (Isturisa), levoketoconazole (Recorlev), pasireotide (Signifor), and mifepristone (Korlym)the latter specifically indicated for hyperglycemia secondary to Cushing's syndrome
[5] Retatrutide in type 2 diabetes, PubMed
Although preliminary evidence is encouraging, comprehensive studies are needed to definitively establish the therapeutic role of L-carnitine in ME/CFS and to optimize its clinical application